Avner Reggev, M.D.
Avner Reggev, MD is an Assistant Attending Physician in Medicine and an Assistant Professor of Medicine in Psychiatry at NewYork Presbyterian Hospital's Westchester Division. He is also an Attending Physician in Medicine at the White Plains Medical Center.
He has held prior positions as an Attending Physician with Mercy Catholic Medical Center in Philadelphia and Community Health Plan of Suffolk in Hauppauge, New York. He received his undergraduate degree from Cornell University and earned his medical degree from the Albert Einstein College of Medicine. He partook in both an internship and residency at the Metropolitan Hospital, New York Medical College and received additional training during an Oncology Fellowship at Mount Sinai Hospital in New York and a Hematology Oncology Fellowship at Mercy Catholic Medical Center in Philadelphia.
Insurance Plans Accepted
The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please feel free to contact this physician or this physician's practice as they may have individual contracts not included on this site.
- AETNA [HMO]
- AETNA [PPO]
- AETNA [Medicare]
- Aetna - Weill Cornell [POS]
- Empire Blue Cross/Blue Shield [HMO]
- Empire Blue Cross/Blue Shield [Mediblue (Senior)]
- Empire Blue Cross/Blue Shield [EPO]
- Empire Blue Cross/Blue Shield [PPO]
- GHI [CBP]
- Health Insurance Plan of NY (HIP)
- Health Insurance Plan of NY (HIP) [Medicare]
- Health Insurance Plan of NY (HIP) [Medicaid]
- Medicare [Medicare]
- Oxford Health Plans [Freedom]
- Oxford Health Plans [Liberty]
- Rockefeller University - CoreSource
- United Empire
- United Health Care
Carraci, G. Reggev, A. Atrail fibrillation and nortriptyline in the elderly. Inter. J. of Geriatric Psych. 1993;8: 577-580
Reggev, A. Vollhardt, B.D. Bradycardia induced by an interation between phenelzine and beta blockers. Psychosomatics. 1989; 30:106
Reggev, A. Djerassi, I. The safety of administration of massive doses of methotrexate with equimolar citrovorum factor rescue in adult patients, Cancer. 1988;61:2423
Djerassi, I. Kim, Kassarov, L. & Reggev, A. Response of mesothelioma to large doses of methotrexate with CF rescue used alone or with cis platinum. Proc. ASCO. 1985;4:191
Djerassi, I. Kim, J.S. Reggev, A. Kassarov, L. Tumor response and survival of patients with stage III primary lung cancer treated with high dose methotrexate and equimolar citrovorum factor rescue. Proc. ASCO 1984;3:244
Reggev, A. Kim, J.S, Kassorov, L & Djerassi, I. Method for safe administration of massive (50grams) doses of methotrexate with equilor citrovorum factor rescue. Proc ASCO, 1984; 3:33
Reggev, A. & Djerassi, I. Rescue from high dose methotrexate with 5-methyletrahydrofalate. Proc AACR. 1983, 24:24;131
Djerassi, I. Kim, J.S. & Reggev, A. Response and long survival in patients with astrocytoma treated with massive doses of methotrexate. Proc ASCO. 1983;2:350.
Reggev, A. Clearance of acid from the esophagus. N. Eng J Med 1984; (letter) 311: 413.
Djerassi, I. and Reggev, A. The nephrotoxitiy of high dose methotrexate with citrovorum factor rescue. Cancer, 1985;55:2741
Djerassi, I. Kim, J.S & Reggev, A., Response of astrocytoma to high dose methotrexate and citrovorum factor rescue. Cancer, 1985; 55: 2741.
Reggev, A. and Djerassi, I. Rescue from high dose metotrexate with 5-methyltetreahydtrofolate. Cancer Treatment Report 1986; 70:251-253
Djerassi, I. Kim, J.S & Reggev, A. High dose methotrexate with citovorum factor rescue in the treatment of malignant astrocytoma. Proc. Of the Chemotherapy, Vienna, Austria. 1983; p 217/1
- Mental Health
- Medical Problems In Psychiatric Illnesses
Contact and Practices
- Internal Medicine
- M.D., Albert Einstein College of Medicine of Yeshiva University, 1976